imidazole has been researched along with von Willebrand Diseases in 2 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cinotti, S | 1 |
Paladino, E | 1 |
Morfini, M | 1 |
Verbruggen, B | 1 |
Giles, A | 1 |
Samis, J | 1 |
Verbeek, K | 1 |
Mensink, E | 1 |
Novákovà, I | 1 |
2 other studies available for imidazole and von Willebrand Diseases
Article | Year |
---|---|
Accuracy of FVIII: C assay by one-stage method can be improved using hemophilic plasma as diluent.
Topics: Blood Coagulation; Blood Coagulation Tests; Buffers; Calibration; Chemistry, Clinical; Factor VII; H | 2006 |
The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
Topics: Blood Coagulation Tests; Buffers; Factor Va; Factor VIII; False Positive Reactions; Hemophilia A; Hu | 2001 |